Poland· PL-100182334

Priorix-Tetra

A masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt product containing szczepionka przeciw odrze, śwince, różyczce, i ospie wietrznej, żywa, registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC J07BD54

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPriorix-TetraATCJ07BD54REGISTER NO.PL-100182334PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BD54 (masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt · ATC J07BD54

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Szczepionka przeciw odrze, śwince, różyczce, i ospie wietrznej, żywa
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Poland (PL)
ATC code
J07BD54
ATC class
Masern, Kombinationen mit Mumps, Röteln und Varicella, lebend abgeschwächt
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909990083022
  • gtin
    05909990083060
  • gtin
    05909990083107
  • gtin
    05909990083121
  • gtin
    05909990083046
  • gtin
    05909990083084

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/140dd699-aee7-4274-ba2f-b51f68fbb70b
GET /v1/drugs/140dd699-aee7-4274-ba2f-b51f68fbb70b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań w ampułko-strzykawce",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990083022 ¦ Rp ¦ 38777\n1 amp.-strzyk.  z rozpuszczalnikiem ¦ 1 fiol.  z proszkiem\n05909990083060 ¦ Rp ¦ 38778\n10 fiol.  z proszkiem ¦ 10 amp.-strzyk.  z rozpuszczalnikiem\n05909990083107 ¦ Rp ¦ Skasowane ¦ 38779\n20 fiol.  proszku ¦ 20 amp.-strzyk. 0,5 ml rozp.\n05909990083121 ¦ Rp ¦ Skasowane ¦ 38780\n50 fiol.  proszku ¦ 50 amp.-strzyk. 0,5 ml rozp.\n05909990083046 ¦ Rp ¦ 38781\n1 fiol.  z proszkiem ¦ 2 igły  ¦ 1 amp.-strzyk.  z rozpuszczalnikiem\n05909990083084 ¦ Rp ¦ 38782\n20 igieł  ¦ 10 amp.-strzyk.  z rozpuszczalnikiem ¦ 10 fiol.  z proszkiem",
  "substance": "Szczepionka przeciw odrze, śwince, różyczce, i ospie wietrznej, żywa patrz: skład produktu leczniczego",
  "common_name": "Szczepionka przeciw odrze, śwince, różyczce, i ospie wietrznej, żywa",
  "pl_product_id": "100182334",
  "pozwolenie_nr": "14231",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.